Sutro Logo high res
  • Who We Are
    • About Sutro
    • Leadership
      • Leadership Team
      • Board of Directors
      • Scientific Advisory Board
      • Clinical Advisory Board
    • Collaborations
  • Proprietary Platform
  • Pipeline
    • Overview
    • Scientific Publications
  • Investors
    • Overview
    • Press Releases
    • Events & Presentations
    • Financials
    • Stock Data
    • Governance
    • IR Resources
  • Careers
    • The Way We Work
    • DEIB
    • Sustainability
    • Internships
    • Philanthropy
      • Employee Engagement
  • Contact Us

Sutro Biopharma Announces the Appointment of Diana Landa as Vice President of Regulatory Affairs and Annie Chang as Head of Investor Relations

News, Press Releases

Sutro Biopharma Announces the Appointment of Diana Landa as Vice President of Regulatory Affairs and Annie Chang as Head of Investor Relations SOUTH SAN FRANCISCO, Calif., Nov. 18, 2020 – Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery,...

Sutro Biopharma to Participate in Four Upcoming Investor Conferences

Events, News, Presentations, Press Releases

Sutro Biopharma to Participate in Four Upcoming Investor Conferences SOUTH SAN FRANCISCO, Calif., Nov. 11, 2020 – Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery, development, and manufacturing company, today announced that Chief Executive...

Sutro Biopharma Reports Third Quarter 2020 Financial Results and Provides Business Highlights and Developments

News, Press Releases

Sutro Biopharma Reports Third Quarter 2020 Financial Results and Provides Business Highlights and Developments – KOL Discussion of STRO-002 Data Event scheduled for December 3rd – Interim Phase 1 data from STRO-001 for patients with NHL will be presented...

Sutro Biopharma Named Best New Drug Developer at the 7th Annual World ADC

Events, News, Press Releases

Sutro Biopharma Named Best New Drug Developer at the 7th Annual World ADC SOUTH SAN FRANCISCO, Calif., Sept. 21, 2020 – Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company today announced that it has been...

Sutro Biopharma Presents Promising STRO-002 Interim Phase 1 Clinical Data in Ovarian Cancer at the 2020 IGCS Annual Global Meeting

Events, News, Presentations, Press Releases

Sutro Biopharma Presents Promising STRO-002 Interim Phase 1 Clinical Data in Ovarian Cancer at the 2020 IGCS Annual Global Meeting Updated Data Further Demonstrate Promising Efficacy and Safety Profile in a Heavily Pretreated Patient Population Not Selected Based on...

Sutro Biopharma to Present at Two Upcoming Investor Conferences

Events, News, Presentations, Press Releases

Sutro Biopharma to Present at Two Upcoming Investor Conferences SOUTH SAN FRANCISCO, Calif., Sept. 3, 2020 – Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company focused on the application of precise protein...
« Older Entries
Next Entries »

Sutro Biopharma

111 Oyster Point Blvd
South San Francisco, CA 94080

Phone: 650-881-6500

Dedicated to patients
and changing the future of oncology

  • Follow
  • Follow
  • Follow
  • Follow

Follow us on social media

© 2026 Sutro Biopharma, Inc.
South San Francisco, California, U.S.A.

SITE MAP | PRIVACY POLICY  | EMAIL ALERTS | CONTACT US | VISITOR GUIDE

 

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in .

Sutro Biopharma, Inc.
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.